4BMRN fundamentals
BIOMARIN PHARMACEUTICAL earnings per share and revenue
4BMRN earnings per share for the last quarter are 0.88 EUR whereas the estimation was 0.63 EUR which accounts for 39.21% surprise. Company revenue for the same period amounts to 688.77 M EUR despite the estimated figure of 682.77 M EUR. Estimated earnings per share for the next quarter are 0.74 EUR, and revenue is expected to reach 674.49 M EUR. Also watch annual changes over time to get a bigger picture of 4BMRN earnings per share and revenue dynamics.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise